nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—NR3C1—Clobetasol propionate—psoriasis	0.142	0.182	CbGbCtD
Podofilox—NR3C1—Fluocinolone Acetonide—psoriasis	0.108	0.138	CbGbCtD
Podofilox—NR3C1—Fluocinonide—psoriasis	0.108	0.138	CbGbCtD
Podofilox—NR3C1—Beclomethasone—psoriasis	0.108	0.138	CbGbCtD
Podofilox—NR3C1—Triamcinolone—psoriasis	0.0429	0.0549	CbGbCtD
Podofilox—NR3C1—Betamethasone—psoriasis	0.0368	0.0471	CbGbCtD
Podofilox—NR3C1—Prednisolone—psoriasis	0.0363	0.0465	CbGbCtD
Podofilox—NR3C1—Hydrocortisone—psoriasis	0.0344	0.0441	CbGbCtD
Podofilox—NR3C1—Prednisone—psoriasis	0.0343	0.0439	CbGbCtD
Podofilox—NR3C1—Dexamethasone—psoriasis	0.0214	0.0274	CbGbCtD
Podofilox—CYP2C19—Cholecalciferol—psoriasis	0.0143	0.0183	CbGbCtD
Podofilox—CYP3A4—Calcitriol—psoriasis	0.0134	0.0171	CbGbCtD
Podofilox—CYP3A4—Methoxsalen—psoriasis	0.0104	0.0133	CbGbCtD
Podofilox—CYP2C19—Prednisone—psoriasis	0.0099	0.0127	CbGbCtD
Podofilox—CYP2C19—Cyclosporine—psoriasis	0.00938	0.012	CbGbCtD
Podofilox—CYP3A4—Cholecalciferol—psoriasis	0.0069	0.00883	CbGbCtD
Podofilox—CYP2C19—Dexamethasone—psoriasis	0.00618	0.00791	CbGbCtD
Podofilox—CYP3A4—Mycophenolate mofetil—psoriasis	0.00598	0.00766	CbGbCtD
Podofilox—CYP3A4—Triamcinolone—psoriasis	0.00598	0.00766	CbGbCtD
Podofilox—CYP3A4—Betamethasone—psoriasis	0.00513	0.00657	CbGbCtD
Podofilox—CYP3A4—Prednisolone—psoriasis	0.00507	0.00648	CbGbCtD
Podofilox—CYP3A4—Hydrocortisone—psoriasis	0.0048	0.00615	CbGbCtD
Podofilox—CYP3A4—Prednisone—psoriasis	0.00478	0.00612	CbGbCtD
Podofilox—CYP3A4—Cyclosporine—psoriasis	0.00454	0.0058	CbGbCtD
Podofilox—CYP3A4—Dexamethasone—psoriasis	0.00299	0.00382	CbGbCtD
Podofilox—Stinging—Triamcinolone—psoriasis	0.000457	0.00215	CcSEcCtD
Podofilox—Swelling—Mycophenolic acid—psoriasis	0.00045	0.00212	CcSEcCtD
Podofilox—Pain—Clobetasol propionate—psoriasis	0.00045	0.00212	CcSEcCtD
Podofilox—Haematuria—Acitretin—psoriasis	0.000444	0.00209	CcSEcCtD
Podofilox—Pruritus—Tazarotene—psoriasis	0.000439	0.00207	CcSEcCtD
Podofilox—Skin discolouration—Hydrocortisone—psoriasis	0.000435	0.00205	CcSEcCtD
Podofilox—Haemoglobin—Acitretin—psoriasis	0.00042	0.00198	CcSEcCtD
Podofilox—Tingling sensation—Betamethasone—psoriasis	0.000418	0.00197	CcSEcCtD
Podofilox—Tingling sensation—Dexamethasone—psoriasis	0.000418	0.00197	CcSEcCtD
Podofilox—Haemorrhage—Acitretin—psoriasis	0.000418	0.00197	CcSEcCtD
Podofilox—Dermatitis bullous—Mycophenolic acid—psoriasis	0.000415	0.00196	CcSEcCtD
Podofilox—Stinging—Dexamethasone—psoriasis	0.000415	0.00195	CcSEcCtD
Podofilox—Stinging—Betamethasone—psoriasis	0.000415	0.00195	CcSEcCtD
Podofilox—Pain—Beclomethasone—psoriasis	0.000409	0.00193	CcSEcCtD
Podofilox—Erythema—Calcitriol—psoriasis	0.000409	0.00193	CcSEcCtD
Podofilox—Pain—Fluocinonide—psoriasis	0.000406	0.00191	CcSEcCtD
Podofilox—Inflammation—Hydrocortisone—psoriasis	0.000405	0.00191	CcSEcCtD
Podofilox—Ulcer—Triamcinolone—psoriasis	0.000392	0.00184	CcSEcCtD
Podofilox—Rash—Tazarotene—psoriasis	0.000391	0.00184	CcSEcCtD
Podofilox—Dermatitis—Tazarotene—psoriasis	0.000391	0.00184	CcSEcCtD
Podofilox—Immune system disorder—Acitretin—psoriasis	0.000377	0.00178	CcSEcCtD
Podofilox—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000376	0.0749	CbGpPWpGaD
Podofilox—Skin exfoliation—Hydrocortisone—psoriasis	0.000375	0.00177	CcSEcCtD
Podofilox—Oedema—Methoxsalen—psoriasis	0.000374	0.00176	CcSEcCtD
Podofilox—Pruritus—Clobetasol propionate—psoriasis	0.000372	0.00175	CcSEcCtD
Podofilox—Erythema—Acitretin—psoriasis	0.000364	0.00171	CcSEcCtD
Podofilox—Skin disorder—Methoxsalen—psoriasis	0.000364	0.00171	CcSEcCtD
Podofilox—Erythema—Fluocinolone Acetonide—psoriasis	0.000363	0.00171	CcSEcCtD
Podofilox—Ulcer—Dexamethasone—psoriasis	0.000355	0.00167	CcSEcCtD
Podofilox—Ulcer—Betamethasone—psoriasis	0.000355	0.00167	CcSEcCtD
Podofilox—Skin exfoliation—Triamcinolone—psoriasis	0.000354	0.00167	CcSEcCtD
Podofilox—Insomnia—Methoxsalen—psoriasis	0.000339	0.00159	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Hydrocortisone—psoriasis	0.000338	0.258	CbGdCrCtD
Podofilox—Dermatitis bullous—Cyclosporine—psoriasis	0.000336	0.00158	CcSEcCtD
Podofilox—Pruritus—Fluocinonide—psoriasis	0.000336	0.00158	CcSEcCtD
Podofilox—Rash—Clobetasol propionate—psoriasis	0.000331	0.00156	CcSEcCtD
Podofilox—Dermatitis—Clobetasol propionate—psoriasis	0.000331	0.00156	CcSEcCtD
Podofilox—Haemoglobin—Hydroxyurea—psoriasis	0.00033	0.00155	CcSEcCtD
Podofilox—Headache—Clobetasol propionate—psoriasis	0.000329	0.00155	CcSEcCtD
Podofilox—Haemorrhage—Hydroxyurea—psoriasis	0.000328	0.00154	CcSEcCtD
Podofilox—Dermatitis bullous—Mycophenolate mofetil—psoriasis	0.000328	0.00154	CcSEcCtD
Podofilox—Skin disorder—Calcitriol—psoriasis	0.000324	0.00153	CcSEcCtD
Podofilox—Skin exfoliation—Betamethasone—psoriasis	0.000321	0.00151	CcSEcCtD
Podofilox—Skin exfoliation—Dexamethasone—psoriasis	0.000321	0.00151	CcSEcCtD
Podofilox—Dizziness—Beclomethasone—psoriasis	0.000316	0.00149	CcSEcCtD
Podofilox—Skin ulcer—Methotrexate—psoriasis	0.000314	0.00148	CcSEcCtD
Podofilox—Dizziness—Fluocinonide—psoriasis	0.000314	0.00148	CcSEcCtD
Podofilox—Ulcer—Prednisone—psoriasis	0.000309	0.00146	CcSEcCtD
Podofilox—Dermatitis bullous—Prednisolone—psoriasis	0.000306	0.00144	CcSEcCtD
Podofilox—Rash—Beclomethasone—psoriasis	0.000302	0.00142	CcSEcCtD
Podofilox—Insomnia—Calcitriol—psoriasis	0.000302	0.00142	CcSEcCtD
Podofilox—Dermatitis—Beclomethasone—psoriasis	0.000301	0.00142	CcSEcCtD
Podofilox—Headache—Beclomethasone—psoriasis	0.0003	0.00141	CcSEcCtD
Podofilox—Rash—Fluocinonide—psoriasis	0.000299	0.00141	CcSEcCtD
Podofilox—Dermatitis—Fluocinonide—psoriasis	0.000299	0.00141	CcSEcCtD
Podofilox—Headache—Fluocinonide—psoriasis	0.000297	0.0014	CcSEcCtD
Podofilox—Oedema—Acitretin—psoriasis	0.000297	0.0014	CcSEcCtD
Podofilox—Oedema—Fluocinolone Acetonide—psoriasis	0.000296	0.00139	CcSEcCtD
Podofilox—Dry skin—Cyclosporine—psoriasis	0.000294	0.00139	CcSEcCtD
Podofilox—Haematuria—Mycophenolic acid—psoriasis	0.000292	0.00137	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Prednisone—psoriasis	0.000291	0.222	CbGdCrCtD
Podofilox—Skin disorder—Acitretin—psoriasis	0.000288	0.00136	CcSEcCtD
Podofilox—Erythema—Hydroxyurea—psoriasis	0.000286	0.00134	CcSEcCtD
Podofilox—Pain—Calcitriol—psoriasis	0.000285	0.00134	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Prednisolone—psoriasis	0.000285	0.217	CbGdCrCtD
Podofilox—Dermatitis bullous—Triamcinolone—psoriasis	0.000281	0.00132	CcSEcCtD
Podofilox—Skin exfoliation—Prednisone—psoriasis	0.000279	0.00132	CcSEcCtD
Podofilox—Haemoglobin—Mycophenolic acid—psoriasis	0.000276	0.0013	CcSEcCtD
Podofilox—Haemorrhage—Mycophenolic acid—psoriasis	0.000275	0.00129	CcSEcCtD
Podofilox—Skin discolouration—Methotrexate—psoriasis	0.000271	0.00128	CcSEcCtD
Podofilox—Insomnia—Acitretin—psoriasis	0.000268	0.00126	CcSEcCtD
Podofilox—Dry skin—Prednisolone—psoriasis	0.000268	0.00126	CcSEcCtD
Podofilox—Paraesthesia—Acitretin—psoriasis	0.000266	0.00126	CcSEcCtD
Podofilox—Pruritus—Methoxsalen—psoriasis	0.000265	0.00125	CcSEcCtD
Podofilox—Dry skin—Hydrocortisone—psoriasis	0.000262	0.00123	CcSEcCtD
Podofilox—Ulcer—Methotrexate—psoriasis	0.000259	0.00122	CcSEcCtD
Podofilox—Dermatitis bullous—Betamethasone—psoriasis	0.000255	0.0012	CcSEcCtD
Podofilox—Dermatitis bullous—Dexamethasone—psoriasis	0.000255	0.0012	CcSEcCtD
Podofilox—Pain—Acitretin—psoriasis	0.000254	0.0012	CcSEcCtD
Podofilox—Pain—Fluocinolone Acetonide—psoriasis	0.000253	0.00119	CcSEcCtD
Podofilox—Inflammation—Methotrexate—psoriasis	0.000252	0.00119	CcSEcCtD
Podofilox—Dizziness—Methoxsalen—psoriasis	0.000248	0.00117	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000241	0.00114	CcSEcCtD
Podofilox—Pruritus—Calcitriol—psoriasis	0.000236	0.00111	CcSEcCtD
Podofilox—Haematuria—Cyclosporine—psoriasis	0.000236	0.00111	CcSEcCtD
Podofilox—Rash—Methoxsalen—psoriasis	0.000236	0.00111	CcSEcCtD
Podofilox—Dermatitis—Methoxsalen—psoriasis	0.000236	0.00111	CcSEcCtD
Podofilox—Headache—Methoxsalen—psoriasis	0.000234	0.0011	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—psoriasis	0.000233	0.0011	CcSEcCtD
Podofilox—Oedema—Hydroxyurea—psoriasis	0.000233	0.0011	CcSEcCtD
Podofilox—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000233	0.0464	CbGpPWpGaD
Podofilox—Haematuria—Mycophenolate mofetil—psoriasis	0.00023	0.00108	CcSEcCtD
Podofilox—Skin disorder—Hydroxyurea—psoriasis	0.000226	0.00107	CcSEcCtD
Podofilox—Dry skin—Dexamethasone—psoriasis	0.000224	0.00105	CcSEcCtD
Podofilox—Dry skin—Betamethasone—psoriasis	0.000224	0.00105	CcSEcCtD
Podofilox—Haemoglobin—Cyclosporine—psoriasis	0.000223	0.00105	CcSEcCtD
Podofilox—Haemorrhage—Cyclosporine—psoriasis	0.000222	0.00105	CcSEcCtD
Podofilox—TOP2A—Norethindrone—Hydrocortisone—psoriasis	0.000221	0.168	CbGdCrCtD
Podofilox—Haemoglobin—Mycophenolate mofetil—psoriasis	0.000218	0.00103	CcSEcCtD
Podofilox—Haemorrhage—Mycophenolate mofetil—psoriasis	0.000217	0.00102	CcSEcCtD
Podofilox—Vomiting—Calcitriol—psoriasis	0.000212	0.000999	CcSEcCtD
Podofilox—Rash—Calcitriol—psoriasis	0.00021	0.000991	CcSEcCtD
Podofilox—Dermatitis—Calcitriol—psoriasis	0.00021	0.00099	CcSEcCtD
Podofilox—Pruritus—Acitretin—psoriasis	0.00021	0.000989	CcSEcCtD
Podofilox—Pruritus—Fluocinolone Acetonide—psoriasis	0.000209	0.000986	CcSEcCtD
Podofilox—Headache—Calcitriol—psoriasis	0.000209	0.000984	CcSEcCtD
Podofilox—Haemoglobin—Prednisolone—psoriasis	0.000203	0.000957	CcSEcCtD
Podofilox—Haemorrhage—Prednisolone—psoriasis	0.000202	0.000952	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000202	0.000952	CcSEcCtD
Podofilox—Pain—Hydroxyurea—psoriasis	0.000199	0.000938	CcSEcCtD
Podofilox—Haemoglobin—Hydrocortisone—psoriasis	0.000198	0.000935	CcSEcCtD
Podofilox—Haemorrhage—Hydrocortisone—psoriasis	0.000197	0.00093	CcSEcCtD
Podofilox—Dizziness—Acitretin—psoriasis	0.000196	0.000924	CcSEcCtD
Podofilox—Dizziness—Fluocinolone Acetonide—psoriasis	0.000196	0.000922	CcSEcCtD
Podofilox—Oedema—Mycophenolic acid—psoriasis	0.000195	0.000919	CcSEcCtD
Podofilox—Dry skin—Prednisone—psoriasis	0.000195	0.000917	CcSEcCtD
Podofilox—Skin disorder—Mycophenolic acid—psoriasis	0.00019	0.000893	CcSEcCtD
Podofilox—Vomiting—Acitretin—psoriasis	0.000189	0.000889	CcSEcCtD
Podofilox—Vomiting—Fluocinolone Acetonide—psoriasis	0.000188	0.000886	CcSEcCtD
Podofilox—Rash—Acitretin—psoriasis	0.000187	0.000881	CcSEcCtD
Podofilox—Dermatitis—Acitretin—psoriasis	0.000187	0.00088	CcSEcCtD
Podofilox—Haemoglobin—Triamcinolone—psoriasis	0.000187	0.00088	CcSEcCtD
Podofilox—Rash—Fluocinolone Acetonide—psoriasis	0.000187	0.000879	CcSEcCtD
Podofilox—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000186	0.000878	CcSEcCtD
Podofilox—Haemorrhage—Triamcinolone—psoriasis	0.000186	0.000876	CcSEcCtD
Podofilox—Headache—Acitretin—psoriasis	0.000186	0.000876	CcSEcCtD
Podofilox—Headache—Fluocinolone Acetonide—psoriasis	0.000185	0.000873	CcSEcCtD
Podofilox—Immune system disorder—Hydrocortisone—psoriasis	0.000178	0.00084	CcSEcCtD
Podofilox—Insomnia—Mycophenolic acid—psoriasis	0.000177	0.000831	CcSEcCtD
Podofilox—Erythema—Prednisolone—psoriasis	0.000176	0.000829	CcSEcCtD
Podofilox—TOP2A—Levonorgestrel—Hydrocortisone—psoriasis	0.000176	0.134	CbGdCrCtD
Podofilox—Paraesthesia—Mycophenolic acid—psoriasis	0.000175	0.000825	CcSEcCtD
Podofilox—Erythema—Hydrocortisone—psoriasis	0.000172	0.00081	CcSEcCtD
Podofilox—Haemoglobin—Betamethasone—psoriasis	0.00017	0.000799	CcSEcCtD
Podofilox—Haemoglobin—Dexamethasone—psoriasis	0.00017	0.000799	CcSEcCtD
Podofilox—Haemorrhage—Dexamethasone—psoriasis	0.000169	0.000795	CcSEcCtD
Podofilox—Haemorrhage—Betamethasone—psoriasis	0.000169	0.000795	CcSEcCtD
Podofilox—Pain—Mycophenolic acid—psoriasis	0.000167	0.000786	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000164	0.00077	CcSEcCtD
Podofilox—Erythema—Triamcinolone—psoriasis	0.000162	0.000762	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—SERPINB8—psoriasis	0.00016	0.0319	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00016	0.000751	CcSEcCtD
Podofilox—Oedema—Cyclosporine—psoriasis	0.000158	0.000744	CcSEcCtD
Podofilox—Dizziness—Hydroxyurea—psoriasis	0.000154	0.000726	CcSEcCtD
Podofilox—Oedema—Mycophenolate mofetil—psoriasis	0.000154	0.000725	CcSEcCtD
Podofilox—Skin disorder—Cyclosporine—psoriasis	0.000153	0.000722	CcSEcCtD
Podofilox—Skin disorder—Mycophenolate mofetil—psoriasis	0.00015	0.000705	CcSEcCtD
Podofilox—TOP2A—G0 and Early G1—PCNA—psoriasis	0.000149	0.0298	CbGpPWpGaD
Podofilox—Vomiting—Hydroxyurea—psoriasis	0.000148	0.000698	CcSEcCtD
Podofilox—Haemoglobin—Prednisone—psoriasis	0.000148	0.000696	CcSEcCtD
Podofilox—Haemorrhage—Prednisone—psoriasis	0.000147	0.000692	CcSEcCtD
Podofilox—Rash—Hydroxyurea—psoriasis	0.000147	0.000692	CcSEcCtD
Podofilox—Erythema—Betamethasone—psoriasis	0.000147	0.000692	CcSEcCtD
Podofilox—Erythema—Dexamethasone—psoriasis	0.000147	0.000692	CcSEcCtD
Podofilox—Dermatitis—Hydroxyurea—psoriasis	0.000147	0.000691	CcSEcCtD
Podofilox—Headache—Hydroxyurea—psoriasis	0.000146	0.000687	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000145	0.000685	CcSEcCtD
Podofilox—Oedema—Prednisolone—psoriasis	0.000144	0.000677	CcSEcCtD
Podofilox—Insomnia—Cyclosporine—psoriasis	0.000143	0.000673	CcSEcCtD
Podofilox—Paraesthesia—Cyclosporine—psoriasis	0.000142	0.000668	CcSEcCtD
Podofilox—Oedema—Hydrocortisone—psoriasis	0.00014	0.000661	CcSEcCtD
Podofilox—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00014	0.0279	CbGpPWpGaD
Podofilox—Insomnia—Mycophenolate mofetil—psoriasis	0.000139	0.000656	CcSEcCtD
Podofilox—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000138	0.000651	CcSEcCtD
Podofilox—Pruritus—Mycophenolic acid—psoriasis	0.000138	0.00065	CcSEcCtD
Podofilox—Skin disorder—Hydrocortisone—psoriasis	0.000136	0.000642	CcSEcCtD
Podofilox—Pain—Cyclosporine—psoriasis	0.000135	0.000636	CcSEcCtD
Podofilox—Immune system disorder—Prednisone—psoriasis	0.000133	0.000625	CcSEcCtD
Podofilox—Oedema—Triamcinolone—psoriasis	0.000132	0.000622	CcSEcCtD
Podofilox—Pain—Mycophenolate mofetil—psoriasis	0.000132	0.00062	CcSEcCtD
Podofilox—Haematuria—Methotrexate—psoriasis	0.00013	0.000614	CcSEcCtD
Podofilox—Insomnia—Prednisolone—psoriasis	0.00013	0.000612	CcSEcCtD
Podofilox—Dizziness—Mycophenolic acid—psoriasis	0.000129	0.000608	CcSEcCtD
Podofilox—Paraesthesia—Prednisolone—psoriasis	0.000129	0.000608	CcSEcCtD
Podofilox—Erythema—Prednisone—psoriasis	0.000128	0.000602	CcSEcCtD
Podofilox—Insomnia—Hydrocortisone—psoriasis	0.000127	0.000598	CcSEcCtD
Podofilox—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000126	0.0252	CbGpPWpGaD
Podofilox—Paraesthesia—Hydrocortisone—psoriasis	0.000126	0.000593	CcSEcCtD
Podofilox—Vomiting—Mycophenolic acid—psoriasis	0.000124	0.000584	CcSEcCtD
Podofilox—Haemoglobin—Methotrexate—psoriasis	0.000123	0.000581	CcSEcCtD
Podofilox—Rash—Mycophenolic acid—psoriasis	0.000123	0.00058	CcSEcCtD
Podofilox—Dermatitis—Mycophenolic acid—psoriasis	0.000123	0.000579	CcSEcCtD
Podofilox—Pain—Prednisolone—psoriasis	0.000123	0.000579	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—psoriasis	0.000123	0.000578	CcSEcCtD
Podofilox—Headache—Mycophenolic acid—psoriasis	0.000122	0.000576	CcSEcCtD
Podofilox—Pain—Hydrocortisone—psoriasis	0.00012	0.000565	CcSEcCtD
Podofilox—Oedema—Betamethasone—psoriasis	0.00012	0.000565	CcSEcCtD
Podofilox—Oedema—Dexamethasone—psoriasis	0.00012	0.000565	CcSEcCtD
Podofilox—Insomnia—Triamcinolone—psoriasis	0.000119	0.000563	CcSEcCtD
Podofilox—Paraesthesia—Triamcinolone—psoriasis	0.000119	0.000559	CcSEcCtD
Podofilox—Pain—Triamcinolone—psoriasis	0.000113	0.000532	CcSEcCtD
Podofilox—Pruritus—Cyclosporine—psoriasis	0.000112	0.000526	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—psoriasis	0.000111	0.000522	CcSEcCtD
Podofilox—Pruritus—Mycophenolate mofetil—psoriasis	0.000109	0.000513	CcSEcCtD
Podofilox—Insomnia—Dexamethasone—psoriasis	0.000108	0.000511	CcSEcCtD
Podofilox—Insomnia—Betamethasone—psoriasis	0.000108	0.000511	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000108	0.000509	CcSEcCtD
Podofilox—Paraesthesia—Betamethasone—psoriasis	0.000108	0.000507	CcSEcCtD
Podofilox—Paraesthesia—Dexamethasone—psoriasis	0.000108	0.000507	CcSEcCtD
Podofilox—Erythema—Methotrexate—psoriasis	0.000107	0.000503	CcSEcCtD
Podofilox—Dizziness—Cyclosporine—psoriasis	0.000104	0.000492	CcSEcCtD
Podofilox—Oedema—Prednisone—psoriasis	0.000104	0.000492	CcSEcCtD
Podofilox—Pain—Dexamethasone—psoriasis	0.000103	0.000483	CcSEcCtD
Podofilox—Pain—Betamethasone—psoriasis	0.000103	0.000483	CcSEcCtD
Podofilox—Dizziness—Mycophenolate mofetil—psoriasis	0.000102	0.00048	CcSEcCtD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—psoriasis	0.000102	0.0203	CbGpPWpGaD
Podofilox—Skin disorder—Prednisone—psoriasis	0.000101	0.000478	CcSEcCtD
Podofilox—Vomiting—Cyclosporine—psoriasis	0.0001	0.000473	CcSEcCtD
Podofilox—Rash—Cyclosporine—psoriasis	9.95e-05	0.000469	CcSEcCtD
Podofilox—Dermatitis—Cyclosporine—psoriasis	9.95e-05	0.000468	CcSEcCtD
Podofilox—Pruritus—Hydrocortisone—psoriasis	9.93e-05	0.000468	CcSEcCtD
Podofilox—Headache—Cyclosporine—psoriasis	9.89e-05	0.000466	CcSEcCtD
Podofilox—Vomiting—Mycophenolate mofetil—psoriasis	9.79e-05	0.000461	CcSEcCtD
Podofilox—Rash—Mycophenolate mofetil—psoriasis	9.71e-05	0.000457	CcSEcCtD
Podofilox—Dermatitis—Mycophenolate mofetil—psoriasis	9.7e-05	0.000457	CcSEcCtD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	9.67e-05	0.0193	CbGpPWpGaD
Podofilox—Headache—Mycophenolate mofetil—psoriasis	9.65e-05	0.000454	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	9.62e-05	0.0192	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.54e-05	0.019	CbGpPWpGaD
Podofilox—Dizziness—Prednisolone—psoriasis	9.5e-05	0.000447	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	9.47e-05	0.0189	CbGpPWpGaD
Podofilox—Insomnia—Prednisone—psoriasis	9.44e-05	0.000445	CcSEcCtD
Podofilox—Paraesthesia—Prednisone—psoriasis	9.37e-05	0.000441	CcSEcCtD
Podofilox—Pruritus—Triamcinolone—psoriasis	9.35e-05	0.00044	CcSEcCtD
Podofilox—Dizziness—Hydrocortisone—psoriasis	9.28e-05	0.000437	CcSEcCtD
Podofilox—NR3C1—Circadian Clock—CARM1—psoriasis	9.2e-05	0.0183	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	9.15e-05	0.0182	CbGpPWpGaD
Podofilox—Rash—Prednisolone—psoriasis	9.06e-05	0.000427	CcSEcCtD
Podofilox—Dermatitis—Prednisolone—psoriasis	9.05e-05	0.000426	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	9.04e-05	0.000426	CcSEcCtD
Podofilox—Headache—Prednisolone—psoriasis	9e-05	0.000424	CcSEcCtD
Podofilox—Vomiting—Hydrocortisone—psoriasis	8.92e-05	0.00042	CcSEcCtD
Podofilox—Rash—Hydrocortisone—psoriasis	8.85e-05	0.000417	CcSEcCtD
Podofilox—Dermatitis—Hydrocortisone—psoriasis	8.84e-05	0.000416	CcSEcCtD
Podofilox—Headache—Hydrocortisone—psoriasis	8.79e-05	0.000414	CcSEcCtD
Podofilox—Dizziness—Triamcinolone—psoriasis	8.74e-05	0.000411	CcSEcCtD
Podofilox—Pruritus—Dexamethasone—psoriasis	8.48e-05	0.000399	CcSEcCtD
Podofilox—Pruritus—Betamethasone—psoriasis	8.48e-05	0.000399	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—psoriasis	8.47e-05	0.000399	CcSEcCtD
Podofilox—Vomiting—Triamcinolone—psoriasis	8.4e-05	0.000396	CcSEcCtD
Podofilox—Rash—Triamcinolone—psoriasis	8.33e-05	0.000392	CcSEcCtD
Podofilox—Dermatitis—Triamcinolone—psoriasis	8.32e-05	0.000392	CcSEcCtD
Podofilox—Headache—Triamcinolone—psoriasis	8.28e-05	0.00039	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	7.97e-05	0.0159	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	7.94e-05	0.0158	CbGpPWpGaD
Podofilox—Dizziness—Betamethasone—psoriasis	7.93e-05	0.000373	CcSEcCtD
Podofilox—Dizziness—Dexamethasone—psoriasis	7.93e-05	0.000373	CcSEcCtD
Podofilox—Insomnia—Methotrexate—psoriasis	7.89e-05	0.000372	CcSEcCtD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	7.84e-05	0.0156	CbGpPWpGaD
Podofilox—Paraesthesia—Methotrexate—psoriasis	7.83e-05	0.000369	CcSEcCtD
Podofilox—Vomiting—Betamethasone—psoriasis	7.62e-05	0.000359	CcSEcCtD
Podofilox—Vomiting—Dexamethasone—psoriasis	7.62e-05	0.000359	CcSEcCtD
Podofilox—Rash—Betamethasone—psoriasis	7.56e-05	0.000356	CcSEcCtD
Podofilox—Rash—Dexamethasone—psoriasis	7.56e-05	0.000356	CcSEcCtD
Podofilox—Dermatitis—Dexamethasone—psoriasis	7.55e-05	0.000356	CcSEcCtD
Podofilox—Dermatitis—Betamethasone—psoriasis	7.55e-05	0.000356	CcSEcCtD
Podofilox—Headache—Betamethasone—psoriasis	7.51e-05	0.000354	CcSEcCtD
Podofilox—Headache—Dexamethasone—psoriasis	7.51e-05	0.000354	CcSEcCtD
Podofilox—Pain—Methotrexate—psoriasis	7.46e-05	0.000351	CcSEcCtD
Podofilox—Pruritus—Prednisone—psoriasis	7.39e-05	0.000348	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptors—VDR—psoriasis	7.38e-05	0.0147	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.21e-05	0.0144	CbGpPWpGaD
Podofilox—Dizziness—Prednisone—psoriasis	6.9e-05	0.000325	CcSEcCtD
Podofilox—Vomiting—Prednisone—psoriasis	6.64e-05	0.000313	CcSEcCtD
Podofilox—Rash—Prednisone—psoriasis	6.58e-05	0.00031	CcSEcCtD
Podofilox—Dermatitis—Prednisone—psoriasis	6.58e-05	0.00031	CcSEcCtD
Podofilox—Headache—Prednisone—psoriasis	6.54e-05	0.000308	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	6.2e-05	0.0124	CbGpPWpGaD
Podofilox—Pruritus—Methotrexate—psoriasis	6.17e-05	0.000291	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PTTG1—psoriasis	5.87e-05	0.0117	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	5.83e-05	0.0116	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.81e-05	0.0116	CbGpPWpGaD
Podofilox—Dizziness—Methotrexate—psoriasis	5.77e-05	0.000272	CcSEcCtD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.74e-05	0.0114	CbGpPWpGaD
Podofilox—Vomiting—Methotrexate—psoriasis	5.55e-05	0.000261	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	5.51e-05	0.011	CbGpPWpGaD
Podofilox—Rash—Methotrexate—psoriasis	5.5e-05	0.000259	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—psoriasis	5.5e-05	0.000259	CcSEcCtD
Podofilox—Headache—Methotrexate—psoriasis	5.47e-05	0.000257	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—PTTG1—psoriasis	5.25e-05	0.0105	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—PPARG—psoriasis	5.15e-05	0.0103	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PTTG1—psoriasis	4.99e-05	0.00995	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—psoriasis	4.82e-05	0.00962	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.71e-05	0.0094	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	4.7e-05	0.00937	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	4.65e-05	0.00927	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ITGAL—psoriasis	4.64e-05	0.00925	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—psoriasis	4.63e-05	0.00923	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	4.59e-05	0.00916	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PTTG1—psoriasis	4.46e-05	0.0089	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL10—psoriasis	4.4e-05	0.00878	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL4—psoriasis	4.28e-05	0.00854	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	4.23e-05	0.00844	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP2S1—psoriasis	4.16e-05	0.0083	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—REN—psoriasis	4.15e-05	0.00827	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	4.11e-05	0.00819	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	4.07e-05	0.00811	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	4.04e-05	0.00805	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	4.03e-05	0.00803	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	3.92e-05	0.00782	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	3.88e-05	0.00774	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—PCNA—psoriasis	3.88e-05	0.00773	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	3.78e-05	0.00753	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	3.71e-05	0.0074	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PTTG1—psoriasis	3.49e-05	0.00696	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	3.41e-05	0.00681	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PTTG1—psoriasis	3.12e-05	0.00622	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	3e-05	0.00598	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—SOCS1—psoriasis	2.99e-05	0.00597	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.94e-05	0.00586	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	2.8e-05	0.00558	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.67e-05	0.00533	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	2.59e-05	0.00517	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—ACE—psoriasis	2.59e-05	0.00516	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TARS—psoriasis	2.58e-05	0.00515	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—LEP—psoriasis	2.54e-05	0.00507	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2S1—psoriasis	2.5e-05	0.00499	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	2.47e-05	0.00492	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.47e-05	0.00492	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	2.41e-05	0.0048	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	2.4e-05	0.00479	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PCNA—psoriasis	2.39e-05	0.00477	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NOS2—psoriasis	2.37e-05	0.00473	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	2.32e-05	0.00463	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	2.28e-05	0.00455	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—JUN—psoriasis	2.24e-05	0.00446	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PPARG—psoriasis	2.21e-05	0.00442	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—LEP—psoriasis	2.21e-05	0.0044	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.16e-05	0.00431	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.14e-05	0.00427	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—PCNA—psoriasis	2.14e-05	0.00426	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	2.12e-05	0.00423	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PCNA—psoriasis	2.03e-05	0.00406	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—psoriasis	2.03e-05	0.00404	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	1.99e-05	0.00397	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	1.97e-05	0.00393	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARG—psoriasis	1.92e-05	0.00384	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NOS2—psoriasis	1.9e-05	0.0038	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	1.9e-05	0.00379	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.86e-05	0.00371	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PCNA—psoriasis	1.82e-05	0.00363	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	1.69e-05	0.00337	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.64e-05	0.00326	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—LEP—psoriasis	1.61e-05	0.0032	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.58e-05	0.00314	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—JUN—psoriasis	1.57e-05	0.00313	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—psoriasis	1.48e-05	0.00295	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.43e-05	0.00285	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PCNA—psoriasis	1.42e-05	0.00284	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.35e-05	0.0027	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.3e-05	0.0026	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PCNA—psoriasis	1.27e-05	0.00254	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.27e-05	0.00253	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.23e-05	0.00244	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.19e-05	0.00238	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—psoriasis	1.18e-05	0.00235	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.18e-05	0.00235	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.14e-05	0.00226	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—psoriasis	1.1e-05	0.0022	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.08e-05	0.00215	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—psoriasis	1.07e-05	0.00213	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—psoriasis	1.04e-05	0.00207	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.03e-05	0.00205	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—psoriasis	1.02e-05	0.00204	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—VDR—psoriasis	1.01e-05	0.00201	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—psoriasis	9.49e-06	0.00189	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	8.83e-06	0.00176	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NDUFA5—psoriasis	8.37e-06	0.00167	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—psoriasis	8.33e-06	0.00166	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—psoriasis	8.24e-06	0.00164	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CARM1—psoriasis	8.12e-06	0.00162	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—psoriasis	7.86e-06	0.00157	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.81e-06	0.00156	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	7.13e-06	0.00142	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2S1—psoriasis	7.12e-06	0.00142	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	7.02e-06	0.0014	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—psoriasis	6.69e-06	0.00133	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NDUFA5—psoriasis	5.04e-06	0.001	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—psoriasis	4.85e-06	0.000967	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—psoriasis	4.68e-06	0.000932	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2S1—psoriasis	4.28e-06	0.000854	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.73e-06	0.000744	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CARM1—psoriasis	3.48e-06	0.000693	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—psoriasis	3.38e-06	0.000674	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.25e-06	0.000648	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CAT—psoriasis	2.14e-06	0.000427	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CARM1—psoriasis	2.09e-06	0.000417	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—psoriasis	1.66e-06	0.000331	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—psoriasis	1.45e-06	0.000289	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CAT—psoriasis	1.29e-06	0.000256	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—psoriasis	9.99e-07	0.000199	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—psoriasis	8.7e-07	0.000174	CbGpPWpGaD
